HCPCS Codes Similar to S9562

HCPCS Codes Similar to “S9562” Code.
Home injectable therapy, palivizumab or other monoclonal antibody for rsv, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

G9839 Anti-egfr monoclonal antibody therapy Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON	G9844 Patient did not receive anti-egfr monoclonal antibody therapy Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON
G9845 Patient received anti-egfr monoclonal antibody therapy Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON	M0235 Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, first dose Code added date: 20251001 Code effective date: 20251001 TXT \| PDF \| XML \| JSON
M0236 Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, second dose Code added date: 20251001 Code effective date: 20251001 TXT \| PDF \| XML \| JSON	Q0235 Injection, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, not otherwise classified, 1 mg Code added date: 20251001 Code effective date: 20251001 TXT \| PDF \| XML \| JSON
J7505 Muromonab-cd3, parenteral, 5 mg Code added date: 19880101 Code effective date: 20190101 TXT \| PDF \| XML \| JSON	S9542 Home injectable therapy, not otherwise classified, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem Code added date: 20020101 Code effective date: 20020101 TXT \| PDF \| XML \| JSON
S9558 Home injectable therapy; growth hormone, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem Code added date: 20020101 Code effective date: 20020101 TXT \| PDF \| XML \| JSON	S9559 Home injectable therapy, interferon, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem Code added date: 20020101 Code effective date: 20020101 TXT \| PDF \| XML \| JSON
S9560 Home injectable therapy; hormonal therapy (e.g.; leuprolide, goserelin), including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem Code added date: 20020101 Code effective date: 20020101 TXT \| PDF \| XML \| JSON	S9563 Home injectable therapy, immunotherapy, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem Code added date: 20230401 Code effective date: 20230401 TXT \| PDF \| XML \| JSON
Q0519 Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days Code added date: 20240915 Code effective date: 20250101 TXT \| PDF \| XML \| JSON	Q0520 Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 60-days Code added date: 20240915 Code effective date: 20250101 TXT \| PDF \| XML \| JSON